These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation]. Dong M; Lin Q; Wu XY Ai Zheng; 2008 Jun; 27(6):646-9. PubMed ID: 18570742 [TBL] [Abstract][Full Text] [Related]
64. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia. Zhang P; Feng K; Xue Y; Zhang CX; Wang Y; Li XL Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):155-161. PubMed ID: 28121342 [TBL] [Abstract][Full Text] [Related]
65. Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation. Chevallier P; Prebet T; Turlure P; Hunault M; Vigouroux S; Harousseau JL; Blaise D; Ifrah N; Milpied N; Mohty M Bone Marrow Transplant; 2010 Jan; 45(1):165-70. PubMed ID: 19584826 [TBL] [Abstract][Full Text] [Related]
66. High-dose corticosteroid associated with catheter-related thrombosis after allogeneic hematopoietic stem cell transplantation. Zhang XH; Feng FE; Han W; Wang FR; Wang JZ; Wang Y; Chen Y; Fu HX; Mo XD; Zhang YY; Yan CH; Chen H; Chen YH; Liu Y; Xu LP; Liu KY; Huang XJ Thromb Res; 2016 Aug; 144():6-11. PubMed ID: 27261538 [TBL] [Abstract][Full Text] [Related]
67. Inhibition of plasminogen activator inhibitor type-1 activity enhances rapid and sustainable hematopoietic regeneration. Ibrahim AA; Yahata T; Onizuka M; Dan T; Van Ypersele De Strihou C; Miyata T; Ando K Stem Cells; 2014 Apr; 32(4):946-58. PubMed ID: 24155177 [TBL] [Abstract][Full Text] [Related]
68. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation. Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127 [TBL] [Abstract][Full Text] [Related]
69. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis. Wu Q; Chen H; Fang J; Xie W; Hong M; Xia L Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312 [TBL] [Abstract][Full Text] [Related]
70. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia]. Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851 [TBL] [Abstract][Full Text] [Related]
71. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease]. Meng XJ; Lin MF; Cai Z Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961 [TBL] [Abstract][Full Text] [Related]
73. [Study on Immunophenotypes and Gene of Acute Lymphoblastic Leukemia--Review]. He YX; Li SD; Wu RH; Qin MQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1831-1835. PubMed ID: 30501729 [TBL] [Abstract][Full Text] [Related]
74. Effects of COVID-19 disease on PAI-1 antigen and haematological parameters during disease management: A prospective cross-sectional study in a regional Hospital in Ghana. Nkansah C; Owusu M; Appiah SK; Mensah K; Bani SB; Osei-Boakye F; Agyemang LD; Ackah EB; Abbam G; Daud S; Quansah Y; Derigubah CA; Apodola FA; Ayangba V; Afrifa DA; Eshun CP; Iddrisu AW; Mintaah S; Twum B; Mohammed A; Agyare EM; Gyasi WA; Agbadza PE; Wilson CAE; Anane S; Antwi P; Antwi RAY PLOS Glob Public Health; 2023; 3(6):e0001866. PubMed ID: 37347738 [TBL] [Abstract][Full Text] [Related]
75. An overview of thrombotic complications of old and new anticancer drugs. Levi M; Sivapalaratnam S Thromb Res; 2020 Jul; 191 Suppl 1():S17-S21. PubMed ID: 32736772 [TBL] [Abstract][Full Text] [Related]
76. Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma. Nomura S; Ito T; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Satake A; Ishii K J Blood Med; 2018; 9():1-7. PubMed ID: 29403323 [TBL] [Abstract][Full Text] [Related]
77. Relationship between changes in selected thrombotic and inflammatory factors, echocardiographic parameters and the incidence of venous thrombosis after pacemaker implantation based on our own observations. Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula-Horowitz K; Majewski J; Ząbek A; Małecka B Arch Med Sci; 2012 Dec; 8(6):1027-34. PubMed ID: 23319977 [TBL] [Abstract][Full Text] [Related]
79. [Clinical significance of plasminogen activator inhibitor-1 (PAI-1) in the early development of HSCT-associated thrombotic complications.]. Han Y; Lu XX; Wu DP; Sun AN; Zhang W; Hu XH; Gao HL; Wang ZY; Ruan CG Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):731-4. PubMed ID: 20137306 [TBL] [Abstract][Full Text] [Related]